It activates the Wnt/β-catenin pathway to promote triple-negative breast cancer (TNBC) progression [21], and targets PTEN to enhance cancer stem cell (CSC)-like properties—including mammosphere formation and tumor initiation [33]. This evidence concerns the gene PTEN and cancer.